Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Cirrhosis

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 91 articles:
HTML format



Single Articles


    February 2024
  1. HE Q, Xiong Y, Xia P, Yang X, et al
    Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    Clin Res Hepatol Gastroenterol. 2024;48:102283.
    PubMed     Abstract available


  2. XIE C, Liu K, Xie Y, Liu S, et al
    Metabolism-related signalling pathways involved in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102264.
    PubMed     Abstract available


    January 2024
  3. KUMAR MS
    Paneth cell: The missing link between obesity, MASH and portal hypertension.
    Clin Res Hepatol Gastroenterol. 2024;48:102259.
    PubMed     Abstract available


  4. SEXTON F, Shanahan W, Ryan JD
    Xanthoma striatum palmare: Getting a handle on hyperlipidaemia in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102255.
    PubMed    


    December 2023
  5. THABUT D, Roux J, Simon-Sultanik P, Tamberou C, et al
    Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: a study of the French Hospital-Discharge Database.
    Clin Res Hepatol Gastroenterol. 2023 Dec 26:102274.
    PubMed     Abstract available


  6. JANG H, Han N, Staatz CE, Kwak JH, et al
    Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023;47:102227.
    PubMed     Abstract available


  7. JIANG R, Zhou Y, Han L, Hong Z, et al
    Serum vitamin D is associated with ultrasound-defined hepatic fibrosis.
    Clin Res Hepatol Gastroenterol. 2023;47:102228.
    PubMed     Abstract available


  8. DONATI A, Henrion J, Regnier M, Deltenre P, et al
    Abstinence is associated with better outcomes in patients with alcohol-related hepatocellular carcinoma: Results of an observational study.
    Clin Res Hepatol Gastroenterol. 2023;47:102225.
    PubMed     Abstract available


    October 2023
  9. CHAIBI S, Larrey E, Couty JP, Sultanik P, et al
    Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC.
    Clin Res Hepatol Gastroenterol. 2023;47:102199.
    PubMed     Abstract available


  10. DUMONT C, Lanthier N, Dahlqvist G
    Fibrosis and steatosis of the liver graft: Are non-invasive tests useful? A short review.
    Clin Res Hepatol Gastroenterol. 2023;47:102194.
    PubMed     Abstract available


    September 2023
  11. MARTINO VD, Questiaux J, Lemagoarou T, Weil D, et al
    Granulocyte Colony Stimulating Factor in decompensated cirrhosis, acute alcoholic hepatitis, and acute-on-chronic liver failure: a comprehensive meta-analysis of randomized controlled trials.
    Clin Res Hepatol Gastroenterol. 2023 Sep 14:102207.
    PubMed     Abstract available


  12. KOUNIS I, Sacleux SC, Ordan MA, Andre S, et al
    Efficiency and safety of total plasma exchange in critically ill cirrhotic patients with acute on chronic liver failure: A pilot study.
    Clin Res Hepatol Gastroenterol. 2023;47:102206.
    PubMed     Abstract available


    August 2023
  13. LU M, Zhu M, Li H, Wang Q, et al
    Factors associated with discordance in the assessment of fibrosis stage between transient elastography and liver biopsy in NAFLD patients.
    Clin Res Hepatol Gastroenterol. 2023;47:102183.
    PubMed     Abstract available


  14. MAMANDIPOOR B, Wernly S, Semmler G, Flamm M, et al
    Machine learning models predict liver steatosis but not liver fibrosis in a prospective cohort study.
    Clin Res Hepatol Gastroenterol. 2023;47:102181.
    PubMed     Abstract available


  15. CALLERI A, Alessandria C
    Renal damage in Hepatorenal Syndrome: A still unsolved issue.
    Clin Res Hepatol Gastroenterol. 2023;47:102178.
    PubMed     Abstract available


    June 2023
  16. WANG X, Xu GH, Yu J, Li H, et al
    When cirrhosis meets paroxysmal nocturnal hemoglobinuria: What kind of "fireworks" scenario will occur?
    Clin Res Hepatol Gastroenterol. 2023;47:102173.
    PubMed    


    May 2023
  17. YAICI L, Gatouillat G, Andreoletti L, N'Guyen Y, et al
    Chronic Hepatitis Delta cirrhosis cured by adapting PEG-IFNalpha-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss.
    Clin Res Hepatol Gastroenterol. 2023 May 25:102148.
    PubMed     Abstract available


  18. RAVAIOLI F, Berger A, Farcau O, Colecchia A, et al
    Individual and population screening of varices needing treatment by a simple, safe and accurate test.
    Clin Res Hepatol Gastroenterol. 2023;47:102123.
    PubMed     Abstract available


  19. MALKANI KV, Jesudian AB, Luo JJ, Schonfeld EA, et al
    Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102114.
    PubMed     Abstract available


  20. MEURER A, Antoni C, Ebert MP, Trimborn A, et al
    Spontaneous bacterial peritonitis caused by Listeria monocytogenes: A rare infection with very high leukocyte counts in ascitic fluid-case report and review of the literature.
    Clin Res Hepatol Gastroenterol. 2023;47:102130.
    PubMed     Abstract available


    April 2023
  21. SASAKI M, Sato Y, Nakanuma Y
    An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2023;47:102106.
    PubMed     Abstract available


    March 2023
  22. CAO L, Qu N, Wang X, Chen L, et al
    The function of long non-coding RNA in non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102095.
    PubMed     Abstract available


    February 2023
  23. IANNONE G, Pompili E, Renzulli M, Caraceni P, et al
    A case of peri-stomal ectopic variceal bleeding in a patient with decompensated cirrhosis treated with TIPS placement.
    Clin Res Hepatol Gastroenterol. 2023 Feb 24:102098.
    PubMed     Abstract available


  24. MURALI AR, Prakash S, Sanchez AJ
    Alpha-1-Antitrypsin Pi*MZ variant increases risk of developing hepatic events in nonalcoholic fatty liver disease patients().
    Clin Res Hepatol Gastroenterol. 2023;47:102066.
    PubMed     Abstract available


    January 2023
  25. BECCHETTI C, Lange NF, Delgado MG, Bronnimann MP, et al
    2D shear wave elastography of the rectus femoris muscle in patients with cirrhosis: feasibility and clinical findings. A pilot study.
    Clin Res Hepatol Gastroenterol. 2023 Jan 16:102080.
    PubMed     Abstract available


  26. OKADA S, Kashima K, Okada K, Okada J, et al
    Aging affects FIB-4 index in the general population without pre-existing diseases: Analysis of a cohort of healthy individuals who underwent annual health checkups for 10 consecutive years.
    Clin Res Hepatol Gastroenterol. 2023;47:102058.
    PubMed    


    October 2022
  27. LIU X, Zhou J, Zhu L, Zhang X, et al
    Diagnostic accuracy of apparent diffusion coefficient values combined with gamma-glutamyl transpeptidase-to-platelet ratio parameters for predicting hepatitis B-related fibrosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101968.
    PubMed     Abstract available


  28. LIU J, Ma Y, Han P, Wang J, et al
    Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis B and metabolic-associated fatty liver disease patients.
    Clin Res Hepatol Gastroenterol. 2022;46:101957.
    PubMed     Abstract available


  29. DING Y, Jiang L, Wang Q, Zhao W, et al
    The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound.
    Clin Res Hepatol Gastroenterol. 2022;46:101951.
    PubMed     Abstract available


  30. LEROY V, Chevaliez S, Decraecker M, Roulot D, et al
    Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus.
    Clin Res Hepatol Gastroenterol. 2022;46:101773.
    PubMed     Abstract available


  31. THABUT D, Weil D, Bouzbib C, Rudler M, et al
    Non-invasive diagnosis and follow-up of portal hypertension.
    Clin Res Hepatol Gastroenterol. 2022;46:101767.
    PubMed     Abstract available


    September 2022
  32. COILLY A, Sebagh M, Fougerou-Leurent C, Pageaux GP, et al
    HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2022 Sep 16:102024.
    PubMed     Abstract available


    August 2022
  33. SOURIANARAYANANE A, McCullough AJ
    Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101997.
    PubMed     Abstract available


  34. CALES P, Ravaioli F, Berger A, Farcau O, et al
    Comparison of screening strategies with two new tests to score and diagnose varices needing treatment.
    Clin Res Hepatol Gastroenterol. 2022;46:101925.
    PubMed     Abstract available


    May 2022
  35. TRIPON S, Bilbault P, Fabacher T, Lefebvre N, et al
    Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19.
    Clin Res Hepatol Gastroenterol. 2022;46:101894.
    PubMed     Abstract available


    April 2022
  36. BOILLOT O, Chopinet S, Gregoire E, Milot L, et al
    Partial splenectomy in children undergoing liver transplantation or venous shunt for severe hypersplenism: a case control comparative study.
    Clin Res Hepatol Gastroenterol. 2022 Apr 21:101929.
    PubMed     Abstract available


  37. WARASNHE K, Ozcay F, Aydin HI, Ozgun G, et al
    A Novel Mutation in TRMT5 Associated with Idiopathic Non-Cirrhotic Portal Hypertension and Hepatopulmonary Syndrome: Case Report of Two Siblings.
    Clin Res Hepatol Gastroenterol. 2022 Apr 20:101928.
    PubMed     Abstract available


  38. AZZI J, Dorival C, Cagnot C, Fontaine H, et al
    Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response.
    Clin Res Hepatol Gastroenterol. 2022 Apr 8:101923.
    PubMed     Abstract available


  39. DUCLOS-VALLEE JC, Debray D, De Martin E, Beux EL, et al
    Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101871.
    PubMed    


  40. WASUWANICH P, So JM, Scheimann AO, Spahic H, et al
    Hepatic and non-hepatic hydrothorax in pediatric ascites.
    Clin Res Hepatol Gastroenterol. 2022;46:101868.
    PubMed     Abstract available


  41. ARTRU F, Moschouri E, Denys A
    Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
    Clin Res Hepatol Gastroenterol. 2022;46:101858.
    PubMed     Abstract available


  42. ZHANG C, Zhang B, Chen A, Yin Q, et al
    Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-beta-mediated fibrosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101833.
    PubMed     Abstract available


    March 2022
  43. DANA J, Girard M, Franchi-Abella S, Berteloot L, et al
    Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101855.
    PubMed     Abstract available


  44. TANG J, Chen C, Zhou M, Wang J, et al
    NLR contributed to the diagnosis and detection of nonalcoholic fatty liver disease: A meta - analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101847.
    PubMed    


  45. SCHAEFER A, Journaux M, Mourabit HE, Mouri S, et al
    A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy.
    Clin Res Hepatol Gastroenterol. 2022;46:101801.
    PubMed     Abstract available


    February 2022
  46. KAPS L, Hildebrand K, Nagel M, Michel M, et al
    Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis.
    Clin Res Hepatol Gastroenterol. 2022 Feb 3:101873.
    PubMed     Abstract available


  47. VITELLIUS C, Paisant A, Lannes A, Chaigneau J, et al
    Liver fibrosis staging by computed tomography: Prospective randomized multicentric evaluation of image analyses.
    Clin Res Hepatol Gastroenterol. 2022;46:101797.
    PubMed     Abstract available


  48. HUANG L, Liu J, Bie C, Liu H, et al
    Advances in cell death - related signaling pathways in acute-on-chronic liver failure.
    Clin Res Hepatol Gastroenterol. 2022;46:101783.
    PubMed     Abstract available


    January 2022
  49. DE LEDINGHEN V
    Non-invasive diagnosis and follow-up of chronic liver disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101763.
    PubMed    


  50. NAHON P, Aube C, Moga L, Chalaye J, et al
    Non-invasive diagnosis and follow-up of primary malignant liver tumours.
    Clin Res Hepatol Gastroenterol. 2022;46:101766.
    PubMed     Abstract available


  51. CORPECHOT C, Heurgue A, Tanne F, Potier P, et al
    Non-invasive diagnosis and follow-up of primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101770.
    PubMed     Abstract available


  52. BOURSIER J, Guillaume M, Bouzbib C, Lannes A, et al
    Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101769.
    PubMed     Abstract available


  53. RAUTOU PE, Elkrief L, Decraecker M, Ollivier-Hourmand I, et al
    Non-invasive diagnosis and follow-up of vascular liver diseases.
    Clin Res Hepatol Gastroenterol. 2022;46:101764.
    PubMed     Abstract available


  54. LEMOINNE S, Heurgue A, Bouzbib C, Hanslik B, et al
    Non-invasive diagnosis and follow-up of autoimmune hepatitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101772.
    PubMed     Abstract available


  55. BOURSIER J, Decraecker M, Bourliere M, Bureau C, et al
    Quality criteria for the measurement of liver stiffness.
    Clin Res Hepatol Gastroenterol. 2022;46:101761.
    PubMed     Abstract available


  56. CHEN BR, Pan CQ
    Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101755.
    PubMed     Abstract available


  57. MAO QG, Liang HQ, Yin YL, Tang JM, et al
    Comparison of Interferon-alpha-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B.
    Clin Res Hepatol Gastroenterol. 2022;46:101758.
    PubMed     Abstract available


  58. ZIMMER V, Emrich K
    Nodular gastric antral vascular ectasia: Distinct portal hypertensive hyperplastic polyp lesions.
    Clin Res Hepatol Gastroenterol. 2022;46:101745.
    PubMed    


    November 2021
  59. SOBOTKA LA, Mumtaz K, Hinton A, Conteh LF, et al
    The Time to Advocate for Influenza Vaccines in Patients with Cirrhosis is Now.
    Clin Res Hepatol Gastroenterol. 2021 Nov 20:101838.
    PubMed     Abstract available


  60. TUTUNCHI H, Naeini F, Ebrahimi-Mameghani M, Najafipour F, et al
    Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study.
    Clin Res Hepatol Gastroenterol. 2021;45:101754.
    PubMed     Abstract available


    October 2021
  61. ZHANG L, Zhou Y, Zhang J
    An incidental hepatic lesion in a cirrhotic liver.
    Clin Res Hepatol Gastroenterol. 2021 Oct 28:101825.
    PubMed    


  62. MOGA L, Robic MA, Blasco-Perrin H, Cabarrou P, et al
    Acute kidney injury in patients with cirrhosis: prospective longitudinal study in 405 patients.
    Clin Res Hepatol Gastroenterol. 2021 Oct 27:101822.
    PubMed     Abstract available


  63. ARTZNER T, Legeai C, Antoine C, Jasseron C, et al
    Liver transplantation for critically ill cirrhotic patients: results from the French transplant registry.
    Clin Res Hepatol Gastroenterol. 2021 Oct 1:101817.
    PubMed     Abstract available


    September 2021
  64. WAHLIN S, Andersson J
    Liver health literacy and social stigma of liver disease: A general population e-survey.
    Clin Res Hepatol Gastroenterol. 2021;45:101750.
    PubMed     Abstract available


    August 2021
  65. BOUZBIB C, El Mourabit H, Wendum D, Lasnier E, et al
    ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy.
    Clin Res Hepatol Gastroenterol. 2021 Aug 9:101784.
    PubMed     Abstract available


    July 2021
  66. TRAN A, Shili-Masmoudi S, Moga L, Chevaliez S, et al
    NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS C VIRUS.
    Clin Res Hepatol Gastroenterol. 2021 Jul 28:101771.
    PubMed     Abstract available


  67. VILLERET F, Dumortier J, Erard-Poinsot D
    How will NAFLD change the liver transplant landscape in the 2020s?
    Clin Res Hepatol Gastroenterol. 2021 Jul 23:101759.
    PubMed     Abstract available


  68. LANTHIER N, Starkel P, Dahlqvist G
    Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?
    Clin Res Hepatol Gastroenterol. 2021;45:101721.
    PubMed     Abstract available


  69. CAMPOS-MURGUIA A, Valdez-Hernandez P, Cordova-Gallardo J, Arteaga-Vazquez J, et al
    Prevalence and clinical characteristics of alpha-1 antitrypsin deficiency in liver explants in a Mexican cohort.
    Clin Res Hepatol Gastroenterol. 2021;45:101519.
    PubMed     Abstract available


    June 2021
  70. QU Y, Li T, Lin C, Liu F, et al
    Animal Naming Test for the Assessment of Minimal Hepatic Encephalopathy in Asian Cirrhotic Populations.
    Clin Res Hepatol Gastroenterol. 2021 Jun 3:101729.
    PubMed     Abstract available


  71. RAZAQ S, Kara M, Ozcakar L
    Measure Grip Strength, Gait Speed and Quadriceps Muscle in Cirrhosis. Comment to "Frailty, sarcopenia and mortality in cirrhosis: What is the best assessment, how to interpret the data correctly and what interventions are possible?"
    Clin Res Hepatol Gastroenterol. 2021 Jun 1:101727.
    PubMed    


    May 2021
  72. KARNSAKUL W, Wasuwanich P, Ingviya T, Laengvejkal P, et al
    Clinical usage of serum albumin to ascitic fluid albumin gradient and ascitic fluid total protein in pediatric ascites.
    Clin Res Hepatol Gastroenterol. 2021;45:101549.
    PubMed     Abstract available


  73. KULKARNI AV, Tevethia HV, Arab JP, Candia R, et al
    Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021;45:101675.
    PubMed     Abstract available


    April 2021
  74. OZCELIK F
    Prognostic value of gamma-glutamyl transpeptidase in liver cirrhosis and hepatocellular cancer regardless of other parameters.
    Clin Res Hepatol Gastroenterol. 2021 Apr 27:101708.
    PubMed    


  75. CARDOSO CC, Matiollo C, Pereira CHJ, Fonseca JS, et al
    B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis.
    Clin Res Hepatol Gastroenterol. 2021 Apr 11:101698.
    PubMed     Abstract available


    March 2021
  76. TORNAI D, Vitalis Z, Jonas A, Janka T, et al
    Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
    Clin Res Hepatol Gastroenterol. 2021;45:101579.
    PubMed     Abstract available


  77. CAO X, Cao Z, Ou C, Zhang L, et al
    Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients.
    Clin Res Hepatol Gastroenterol. 2021;45:101583.
    PubMed     Abstract available


  78. CORPECHOT C
    The revival of preemptive UDCA therapy in liver transplant recipients: Commentary to "UDCA decreases Incidence of Primary Biliary Cholangitis and Biliary Complications after Liver Transplant: A Meta-Analysis" by Pedersen et al., Liver Transplant, Nove
    Clin Res Hepatol Gastroenterol. 2021 Mar 13:101679.
    PubMed    


  79. LANTHIER N, Starkel P, Dahlqvist G
    Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?
    Clin Res Hepatol Gastroenterol. 2021 Mar 2:101661.
    PubMed     Abstract available


  80. DI GIORGIO A, Nicastro E, Arnaboldi S, Montini O, et al
    "Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study".
    Clin Res Hepatol Gastroenterol. 2021;45:101610.
    PubMed    


  81. LIU Y, Wu H, Wang Z, Wu J, et al
    Integrated expression profiles of mRNA and miRNA in a gerbil model of fatty liver fibrosis treated with exenatide.
    Clin Res Hepatol Gastroenterol. 2021;45:101312.
    PubMed     Abstract available


  82. XIE Z, Wu Y, Liu S, Lai Y, et al
    LncRNA-SNHG7/miR-29b/DNMT3A axis affects activation, autophagy and proliferation of hepatic stellate cells in liver fibrosis.
    Clin Res Hepatol Gastroenterol. 2021;45:101469.
    PubMed     Abstract available


  83. XIE X, Feng Y, Lyu Z, Wang L, et al
    Liver stiffness as measured by two-dimensional shear wave elastography overestimates the stage of fibrosis in patients with chronic hepatitis B and hepatic steatosis.
    Clin Res Hepatol Gastroenterol. 2021;45:101421.
    PubMed     Abstract available


    February 2021
  84. GAO Y, Liu H, Tang F, Zhang X, et al
    Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021 Feb 15:101649.
    PubMed     Abstract available


    January 2021
  85. ZHAO N, Liu X, Guo H, Zhao X, et al
    Interleukin-35: An emerging player in the progression of liver diseases.
    Clin Res Hepatol Gastroenterol. 2021;45:101518.
    PubMed     Abstract available


  86. ALLAIRE M, El Hajj W, Brichler S, Diallo K, et al
    Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the West.
    Clin Res Hepatol Gastroenterol. 2021;45:101436.
    PubMed     Abstract available


  87. KANG Y, Park S, Kim S, Han SJ, et al
    Validating the BAVENO VI criteria to identify low risk biliary atresia patients without endoscopy for esophageal varix.
    Clin Res Hepatol Gastroenterol. 2021;45:101437.
    PubMed     Abstract available


  88. RAFFETTI E, Portolani N, Molfino S, Mentasti S, et al
    Is survival for hepatocellular carcinoma increasing? A population-based study on survival of hepatocellular carcinoma patients in the 1990s and 2000s.
    Clin Res Hepatol Gastroenterol. 2021;45:101433.
    PubMed     Abstract available


    November 2020
  89. HUANG C, Seah JJ, Tan CK, Kam JW, et al
    Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101528.
    PubMed     Abstract available


    December 2019
  90. PETIT PR, Borentain P, Aherfi S, Gerolami R, et al
    Hepatitis Delta recurrence post-liver transplantation in absence of detectable hepatitis B surface antigen and hepatitis B virus DNA in peripheral blood.
    Clin Res Hepatol Gastroenterol. 2019 Dec 28. pii: S2210-7401(19)30258.
    PubMed    


    June 2019
  91. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.